Additionally, and probably not independently form the above mentioned findings, recent studies demonstrated ‘CD44’ as a potential tumour stem cell marker (in colorectal, gastric and pancreatic adenocarcinoma, as well as breast cancer and other cancers) [32-39]. This evidence concerns the gene CD44 and neoplasm.